L26/P-265 Trends in first-cycle and cumulative live birth rates in the United States
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Herweck und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What are first-cycle and cumulative live birth rates following in vitro fertilization in the United States in 2019 compared with published national outcomes from 2004-2009? Summary answer Among US patients younger than 40 years undergoing IVF in 2019, first-cycle LBRs exceeded prior decades, while cumulative rates after three cycles were similar. What is known already Since the birth of the first IVF infant in 1978, IVF techniques have evolved, resulting in substantial improvements in treatment effectiveness. Present-day IVF is more effective than in prior decades, and utilisation has increased as more individuals and couples seek fertility care. In addition, access to IVF in the US has expanded through state mandates and employer-sponsored fertility benefits. Prior studies demonstrate that advances in laboratory techniques and clinical protocols have improved both per-cycle and cumulative IVF success. However, continuous evaluation of IVF effectiveness is necessary to inform evidence-based decisions regarding coverage, access, and treatment continuation. Study design, size, duration We conducted a retrospective cohort study using US national IVF data from the 2019 Society of Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS). The cohort included 42,448 patients undergoing their first IVF cycle, with outcomes tracked for 36 to 48 months. Follow-up continued until the first IVF live birth or December 31, 2022, allowing estimation of both first-cycle and cumulative live birth outcomes. Participants/materials, setting, methods We included US patients younger than 40 years undergoing their first autologous IVF cycle in 2019 using their own uterus, with known outcomes reported to SART CORS. Cycles were limited to 13 states and the District of Columbia, representing 57% of the US population. We excluded donor oocytes or embryo cycles, gestational carrier cycles, fertility preservation, natural or minimal-stimulation IVF with non-gonadotropin protocols, and cases with unknown outcomes. Live birth was the primary outcome. Main results and the role of chance First-cycle LBRs were high. Among patients younger than 35 years, 64% achieved a live birth after the first IVF cycle (73% when at least one blastocyst transfer occurred), with cumulative LBRs reaching 74% after up to three cycles. Among patients aged 35-37 years, first-cycle LBR was 51%, increasing to 62% cumulatively. Among patients aged 38-39 years, first-cycle LBR was 37%, with cumulative rates of 48%. When compared with national IVF outcomes reported by Luke et al. (NEJM, 2012), which analyzed US IVF cycles from 2004-2009, first-cycle outcomes in 2019 approximated outcomes that previously required three IVF cycles. Luke et al. reported cumulative LBRs after up to 3 cycles of approximately 61% among patients younger than 35 years, 50% among those aged 35-37 years, and 35% among those aged 38-40 years-rates comparable to first-cycle outcomes observed in 2019. First-cycle LBR increased by 57% among patients younger than 35 years (41% to 64%), by 59% among those aged 35-37 years (32% to 51%), and by 68% among those aged 38-39 years (22% to 37%). Overall, first-cycle and cumulative LBRs were 56% and 66%, respectively, compared with 31% and 48% reported in prior decades. Limitations, reasons for caution Limitations include patients younger than 40 years and comparison with a historical cohort that included age 40 within the 38-40 group. Findings are not generalizable to donor oocytes or gestational carrier cycles. Differential treatment continuation after failed IVF cycles may influence cumulative outcomes regionally. Follow-up was limited to three cycles. Wider implications of the findings These findings reinforce IVF as a highly effective component of reproductive care and may inform health policy regarding access and coverage. Ongoing analyses will evaluate factors influencing outcomes and support development of predictive models to guide evidence-based clinical practice and policy decisions. Trial registration number No
Zitieren
APA
Herweck, A., Nguyen, E., Feinberg, E., & Yao, M. (2026). L26/P-265 Trends in first-cycle and cumulative live birth rates in the United States. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.601
Vancouver
Herweck A, Nguyen E, Feinberg E, Yao M. L26/P-265 Trends in first-cycle and cumulative live birth rates in the United States. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.601
BibTeX
@article{Herweck2026,
author = {Herweck, A. and Nguyen, E. and Feinberg, E. and Yao, M.},
title = {L26/P-265 Trends in first-cycle and cumulative live birth rates in the United States},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.601}
}
EUVIMED